SCHEMBL2301655

SCHEMBL2301655

CCc1c(C(=O)O)ccc(O)c1C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSNK2A1 P68400 1/20 0.46
SELL P14151 1/20 0.45
SELP P16109 1/20 0.45
SLC22A6 Q4U2R8 1/20 0.44
SLC22A8 Q8TCC7 1/20 0.44
MYC P01106 2/20 0.41
MCL1 Q07820 3/20 0.41
KLKB1 P03952 2/20 0.40
CTSB P07858 2/20 0.40
MMP9 P14780 2/20 0.40
DNMT1 P26358 1/20 0.40
DNMT3B Q9UBC3 1/20 0.40
DNMT3L Q9UJW3 1/20 0.40
DNMT3A Q9Y6K1 1/20 0.40
ESR1 P03372 2/20 0.40
ESR2 Q92731 2/20 0.40
GABRP O00591 1/20 0.40
GABRD O14764 1/20 0.40
GABRA1 P14867 1/20 0.40
GABRB1 P18505 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10901788 0.86 GABRP (0.43) CSNK2A1MYCGABRPGABRDGABRA1
SCHEMBL12501719 0.85 MCL1 (0.47) CSNK2A1SELLSELPSLC22A6SLC22A8
SCHEMBL28670020 0.85 CSNK2A1 (0.46) CSNK2A1SELLSELPSLC22A6SLC22A8
SCHEMBL542401 0.84 SELL (0.48) CSNK2A1SELLSELPMCL1KLKB1
SCHEMBL31668786 0.84 SELL (0.48) CSNK2A1SELLSELPMCL1KLKB1
SCHEMBL28623909 0.84 KAT8 (0.50) CSNK2A1SELLSELPSLC22A6SLC22A8
SCHEMBL7072975 0.82 GABRP (0.41) MYCMCL1GABRPGABRDGABRA1
SCHEMBL39790 0.82 SELL (0.57) CSNK2A1SELLSELPMCL1KLKB1
SCHEMBL294836 0.81 CYP1A2 (0.50) SELLSELPGABRPGABRDGABRA1
SCHEMBL18419577 0.81 SELL (0.45) CSNK2A1SELLSELPMCL1KLKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113748021-A Method for producing liquid crystal polyester processed product 本州化学工业株式会社 2021-12-03 CN disclosed
CN-113285024-A Semiconductor device having quantum dots, display device, imaging system, and moving object 佳能株式会社 2021-08-20 CN disclosed
EP-2349983-B1 DIFLUORPHENYL DIACYLHYDRAZIDE DERIVATES MERCK PATENT GMBH (DE) 2016-09-14 EP disclosed
EP-2349983-B1 DIFLUORPHENYL DIACYLHYDRAZIDE DERIVATES MERCK PATENT GMBH (DE) 2016-09-14 EP disclosed
US-8492440-B2 Difluorophenyldiacylhydrazide derivatives MERCK PATENT GMBH (DE) 2013-07-23 US disclosed
US-8492440-B2 Difluorophenyldiacylhydrazide derivatives MERCK PATENT GMBH (DE) 2013-07-23 US disclosed
US-8492440-B2 Difluorophenyldiacylhydrazide derivatives MERCK PATENT GMBH (DE) 2013-07-23 US disclosed
US-20110224302-A1 DIFLUOROPHENYLDIACYLHYDRAZIDE DERIVATIVES MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2011-09-15 US disclosed
US-20110224302-A1 DIFLUOROPHENYLDIACYLHYDRAZIDE DERIVATIVES MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2011-09-15 US disclosed
US-20110224302-A1 DIFLUOROPHENYLDIACYLHYDRAZIDE DERIVATIVES MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2011-09-15 US disclosed
EP-2349983-A2 DIFLUORPHENYL DIACYLHYDRAZIDE DERIVATES Merck Patent GmbH (DE) 2011-08-03 EP disclosed
WO-2010060522-A2 DIFLUORPHENYL DIACYLHYDRAZIDE DERIVATES MERCK PATENT GMBH (DE) 2010-06-03 WO disclosed
WO-2010060522-A2 DIFLUORPHENYL DIACYLHYDRAZIDE DERIVATES MERCK PATENT GMBH (DE) 2010-06-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110224302-A1 DIFLUOROPHENYLDIACYLHYDRAZIDE DERIVATIVES FGFR1, PKD1, AGTR1 CSNK2A1 1235/4885SELL 3355/4885SELP 3861/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.